| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/08/1997 | EP0751934A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |
| 01/08/1997 | EP0751926A1 Enhancement of the efficacy of drugs by deuteration |
| 01/08/1997 | EP0751785A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 01/08/1997 | EP0751784A1 Thyroxin-binding proteins |
| 01/08/1997 | EP0751783A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives |
| 01/08/1997 | EP0751775A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives |
| 01/08/1997 | EP0751774A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives |
| 01/08/1997 | EP0751773A1 Tocolytic oxytocin receptor antagonists |
| 01/08/1997 | EP0751769A1 Medical treatment using thyroid hormones |
| 01/08/1997 | EP0751767A1 Therapeutic guanidines |
| 01/08/1997 | EP0668863B1 Quinuclidine derivative as substance p antagonist |
| 01/08/1997 | EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/08/1997 | CN1139932A N-terminally chemically modified protein compositions and methods |
| 01/08/1997 | CN1139929A Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
| 01/08/1997 | CN1139928A Novel compound |
| 01/08/1997 | CN1139917A Calcium receptor-active arylalkyl amines |
| 01/08/1997 | CN1139666A Novel tricyclic amide, its preparation method and medicinal combination |
| 01/07/1997 | US5591891 N-[Mercaptoacyl (amino acid or peptide ) ] compounds and S-lipophiIic aliphatic carbonyl derivatives thereof as antihypertensives |
| 01/07/1997 | US5591835 Substituted lactose derivatives |
| 01/07/1997 | US5591775 Sleep disorders |
| 01/07/1997 | US5591769 Cyclic imino derivatives and pharmaceutical compositions containing them |
| 01/07/1997 | US5591761 Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/07/1997 | US5591758 Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases |
| 01/07/1997 | US5591757 Dihydropyridine composition |
| 01/07/1997 | US5591754 Benzoylguanidines, pharmaceutical composition containing them and treatment of arrthythmias therewith |
| 01/07/1997 | US5591751 Peripheral vasodilators |
| 01/07/1997 | US5591746 Glutamate inhibitors; central nervous system disorders |
| 01/07/1997 | US5591743 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligands |
| 01/07/1997 | US5591742 Treatment of angina, hypertension, atherosclerosis, cardiovascular disorders |
| 01/07/1997 | US5591735 Androstane derivatives substituted by a quaternary ammonium group in 16-position, pharmaceutical compositions containing them and process for preparing same |
| 01/07/1997 | US5591734 17-(3-furyl)-5β, 14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 01/07/1997 | US5591728 New phosphonic acid compounds |
| 01/07/1997 | CA2038097C Method and composition for coiontophoresis |
| 01/07/1997 | CA2033497C 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/07/1997 | CA2024381C Xanthine compounds |
| 01/07/1997 | CA2011329C Xanthine derivatives |
| 01/07/1997 | CA2004606C Process for preparing optically active 2-oxoimidazolidine derivatives |
| 01/07/1997 | CA1338836C Endotoxin binding protein and uses thereof |
| 01/05/1997 | CA2180294A1 Method for the preparation of n-substituted 4-ketoproline derivatives |
| 01/03/1997 | WO1997000261A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 01/03/1997 | WO1997000251A1 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 01/03/1997 | WO1997000079A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | WO1997000074A1 USE OF IMIDAZO[1,5-a]QUINOLONES AS NEUROPROTECTIVE AGENTS |
| 01/03/1997 | WO1997000063A2 Urocortin peptides |
| 01/03/1997 | CA2224625A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | CA2224555A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 01/03/1997 | CA2223792A1 Urocortin peptides |
| 01/02/1997 | EP0751129A1 Substituted dihydrodibenzo/b, f/azepines, method for their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them |
| 01/02/1997 | EP0750912A2 Batroxobin containing medicaments for the treatment or prophylaxis of ischemia-reperfusion injury |
| 01/02/1997 | EP0750909A1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |
| 01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 01/02/1997 | EP0750631A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
| 01/02/1997 | EP0750621A1 Heterocyclic compounds, their preparation and use |
| 01/02/1997 | EP0750617A1 Novel heterocyclic ethanolamine derivatives with beta-adrenoreceptor agonistic activity |
| 01/02/1997 | EP0750614A1 Quinazolinyl-amino derivatives having alpha-antagonist activity |
| 01/02/1997 | EP0750608A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker |
| 01/02/1997 | EP0750503A1 Ribozyme therapy for restenosis |
| 01/02/1997 | EP0550631B1 Compounds having antihypertensive and anti-ischemic properties |
| 01/01/1997 | CN1139455A Thrombin mutants |
| 01/01/1997 | CN1139435A New ginkgolide derivatives and process for preparing them |
| 01/01/1997 | CN1139431A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders |
| 01/01/1997 | CN1138987A Jiuxin medicinal liquor preparation |
| 12/31/1996 | US5589572 Process for production of inhibited forms of activated blood factors |
| 12/31/1996 | US5589571 Process for production of inhibited forms of activated blood factors |
| 12/31/1996 | US5589509 Enhancing effect of administered tumor cell-locating porphyrins in light irradiation to destroy tumor cells |
| 12/31/1996 | US5589501 Pharmaceutical compounds |
| 12/31/1996 | US5589496 Fused benzeneoxyacetic acid derivatives which have PGI2 receptor agonist activity |
| 12/31/1996 | US5589490 Benzoic acid substituted derivatives having cardiovascular activity |
| 12/31/1996 | US5589486 N-hydroxyalkyl-substituted 1,2,3,6-tetrahydro-pyridine and piperidine derivatives |
| 12/31/1996 | US5589471 Vitamin D analogues containing a hydroxy or alkylated hydroxy group in the 20-position |
| 12/31/1996 | US5589459 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |
| 12/31/1996 | US5589358 Ileal bile acid transporter compositions and methods |
| 12/31/1996 | US5589338 Nucleic acids encoding a mutant form of human serum albumin involved in familial dysalbuminemic hyperthyroxinemia |
| 12/31/1996 | US5589154 Diagnosing presence of b-amyloid peptide |
| 12/31/1996 | US5589047 Using dielectrophoresis for genetic engineering |
| 12/31/1996 | CA2092983C Hydroxylated metabolites and derivatives of doxazosin as anti-atherosclerosis agents |
| 12/27/1996 | WO1996041807A1 Rapamycin derivatives |
| 12/27/1996 | WO1996041795A1 Benzamide derivatives and their use as vasopressin antagonists |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | WO1996041624A1 TNF-α CONVERTING ENZYME |
| 12/27/1996 | EP0749977A2 Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same |
| 12/27/1996 | EP0749967A1 Substituted benzothiazine derivative |
| 12/27/1996 | EP0749964A1 N-Heterocyclyl biphenyl sulfonamides |
| 12/27/1996 | EP0749752A1 Use of specific RXR receptor ligands |
| 12/27/1996 | EP0749582A1 Methods of diagnosing and treating preeclampsia |
| 12/27/1996 | EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof |
| 12/27/1996 | EP0749478A1 Yeast strains and modified albumins |
| 12/27/1996 | EP0749424A1 Naphthalene derivatives as prostaglandin i2 agonists |
| 12/27/1996 | EP0749320A1 Fibrin-specific antibody for use as an antithrombotic agent |
| 12/27/1996 | EP0749316A1 Antithrombotic agents |
| 12/27/1996 | EP0749313A1 Method for treating 5ht 2b receptor related conditions |
| 12/27/1996 | EP0749307A1 Isoxazoline compounds as 5-lipoxygenase inhibitors |
| 12/27/1996 | EP0749306A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 12/27/1996 | CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | CA2223869A1 Benzamide derivatives and their use as vasopressin antagonists |
| 12/25/1996 | CN1138851A Metalloproteinase inhibitors |